In the present investigation, we looked at the effects of QFM combined with PD-1 inhibitor on tryptophan metabolic reprogramming pathway in vitro and in vivo, which provided a novel route for the synergistic immunotherapy research of QFM in lung cancer. This evidence concerns the gene PDCD1 and lung carcinoma.